A health worker administers a dose of the AstraZeneca vaccine against COVID-19 to a patient inside the convention center known as "La Nuvola", The Cloud, in Rome, Wednesday, March 10, 2021. (AP/Andrew Medichini)
Denmark, Norway and Iceland all temporarily suspend the use of AstraZeneca’s COVID-19 vaccine over concerns about patients developing post-shot blood clots, as the manufacturer and Europe’s medicine watchdog insist the vaccine is safe.
Denmark is first to announce its suspension, “following reports of serious cases of blood clots” among people who had received the vaccine, the country’s Health Authority says in a statement.
It stresses the move is precautionary, and that “it has not been determined, at the time being, that there is a link between the vaccine and the blood clots.”
As of March 9, 22 cases of blood clots have been reported among more than three million people vaccinated in the European Economic Area, the European Medicines Agency (EMA) says.
Austria announced on Monday that it had suspended the use of a batch of AstraZeneca vaccines after a 49-year-old nurse died of “severe blood coagulation problems” days after receiving a shot.
A health worker prepares a dose of the AstraZeneca COVID-19 vaccine to be administered at a vaccination center set up in front of Rome’s Termini central station, Monday, March 8, 2021. (AP Photo/Alessandra Tarantino)
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel